| Dr Adityanant Jain, DO | |
|
2875 Nw Stucki Ave, Hillsboro, OR 97124-5806 | |
| (971) 310-1000 | |
| Not Available |
| Full Name | Dr Adityanant Jain |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 2875 Nw Stucki Ave, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184940934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | Q0077 (Texas) | Secondary |
| 207R00000X | Internal Medicine | DO171278 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Westside | Hillsboro, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
New York city officials say a man has been hospitalized with an infection from anthrax.
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.
› Verified 9 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
New York city officials say a man has been hospitalized with an infection from anthrax.
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adityanant Jain, DO 2875 Nw Stucki Ave, Hillsboro, OR 97124-5806 Ph: () - | Dr Adityanant Jain, DO 2875 Nw Stucki Ave, Hillsboro, OR 97124-5806 Ph: (971) 310-1000 |
News Archive
A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.
The ultimate goal in cancer research, a treatment that kills cancer cells whilst leaving healthy cells untouched, is brought nearer by the success of a new therapeutic approach. The potential therapy, published in BioMed Central's open access journal Breast Cancer Research, targets proliferation of cancer, but not normal, cells.
New York city officials say a man has been hospitalized with an infection from anthrax.
Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.
› Verified 9 days ago
Raeesa Khalid, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1050 Fax: 503-681-1939 | |
Kishoree Jayant Patel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 19400 Evergreeen Pwy, Hillsboro, OR 97124 Phone: 503-645-2762 | |
Marsha D Ware, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 18610 Nw Cornell Rd, Suite 101, Hillsboro, OR 97124 Phone: 503-216-9360 | |
Mustaquim Faruq Chowdhury, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 364 Se 8th Ave Ste 301, Hillsboro, OR 97123 Phone: 503-681-4233 Fax: 503-681-4234 | |
Scot T Smith, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1111 | |
Nancy Heather Vinikoor, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 17770 Sw Neugebauer Rd, Hillsboro, OR 97123 Phone: 503-628-9120 | |
Meenakshi Narasimhamurthy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 730 Se Oak St Ste I, Hillsboro, OR 97123 Phone: 503-430-0497 Fax: 503-747-5985 |